Cytosorbents Corporation
NASDAQ:CTSO
Overview | Financials
Company Name | Cytosorbents Corporation |
Symbol | CTSO |
Currency | USD |
Price | 0.871 |
Market Cap | 47,380,967 |
Dividend Yield | 0% |
52-week-range | 0.7 - 2.15 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Phillip P. Chan M.D., Ph.D. |
Website | https://www.cytosorbents.com |
An error occurred while fetching data.
About Cytosorbents Corporation
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD